Can variation in hypothalamic-pituitary-adrenal (HPA)-axis activity explain the relationship between depression and cognition in bipolar patients?

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  van der Werf Eldering, Marieke J ^a   Riemersma van der Lek, Rixt F ^a   Burger, Huibert ^a   Holthausen, Esther A E ^a   Aleman, André ^b   Nolen, Willem A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; HYDROCORTISONE; LITHIUM; NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; ATTENTION; BIPOLAR DISORDER; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CIRCADIAN RHYTHM; COGNITION; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EXECUTIVE FUNCTION; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NERVOUS SYSTEM PARAMETERS; OUTCOME ASSESSMENT; PSYCHOMOTOR ACTIVITY; REGRESSION ANALYSIS; VERBAL MEMORY; VISUAL MEMORY; AFFECT; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SALIVA;

ADULT; AFFECT; BIPOLAR DISORDER; CIRCADIAN RHYTHM; COGNITION; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; SALIVA;

EID: 84860995476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037119     Document Type: Article

References (52)

1. McDermott LM, Ebmeier KP, (2009) A meta-analysis of depression severity and cognitive function. J Affect Disord 119 (1-3): 1-8.
2. Kurtz MM, Gerraty RT, (2009) A meta-analytic investigation of neurocognitive deficits in bipolar illness: Profile and effects of clinical state. Neuropsychology 23 (5): 551-562.
3. Torres IJ, Boudreau VG, Yatham LN, (2007) Neuropsychological functioning in euthymic bipolar disorder: A meta-analysis. Acta Psychiatr Scand (suppl 434): 17-26.
4. Robinson LJ, Thompson JM, Gallagher P, Goswami U, Young AH, et al. (2006) A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93 (1-3): 105-115.
5. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH, (2004) Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184: 496-502.
6. Gallagher P, Malik N, Newham J, Young AH, Ferrier IN, et al. (2008) Antiglucocorticoid treatments for mood disorders. Cochrane Database Syst Rev.
7. Spijker AT, van Rossum EF, (2009) Glucocorticoid receptor polymorphisms in major depression. focus on glucocorticoid sensitivity and neurocognitive functioning. Ann N Y Acad Sci 1179: 199-215.
8. Heuser I, Yassouridis A, Holsboer F, (1994) The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatr Res 28 (4): 341-356.
9. Holsboer F, (2000) The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23 (5): 477-501.
10. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, et al. (1981) A specific laboratory test for the diagnosis of melancholia. standardization, validation, and clinical utility. Arch Gen Psychiatry 38 (1): 15-22.
11. Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, et al. (2009) Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: Results from a large cohort study. Arch Gen Psychiatry 66 (6): 617-626.
12. Deshauer D, Duffy A, Alda M, Grof E, Albuquerque J, et al. (2003) The cortisol awakening response in bipolar illness: A pilot study. Can J Psychiatry 48 (7): 462-466.
13. Daban C, Vieta E, Mackin P, Young AH, (2005) Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 28 (2): 469-480.
14. Jabben N, Nolen WA, Smit JH, Vreeburg SA, Beekman AT, et al. (2011) Co-occurring manic symptomatology influences HPA axis alterations in depression. J Psychiatr Res 45: 1208-1213.
15. Porter RJ, Gallagher P, (2006) Abnormalities of the HPA axis in affective disorders: Clinical subtypes and potential treatments. Acta Neuropsychiatrica 18: 193-209.
16. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR Jr, et al. (1996) The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57 (10): 470-484.
17. McQuade R, Young AH, (2000) Future therapeutic targets in mood disorders: The glucocorticoid receptor. Br J Psychiatry 177: 390-395.
18. Lupien SJ, McEwen BS, (1997) The acute effects of corticosteroids on cognition: Integration of animal and human model studies. Brain Res Brain Res Rev 24 (1): 1-27.
19. Liston C, McEwen BS, Casey BJ, (2009) Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc Natl Acad Sci U S A 106 (3): 912-917.
20. Beluche I, Carriere I, Ritchie K, Ancelin ML, (2010) A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med 40 (6): 1039-1049.
21. Brown ES, (2009) Effects of glucocorticoids on mood, memory, and the hippocampus. treatment and preventive therapy. Ann N Y Acad Sci 1179: 41-55.
22. Brown ES, Rush AJ, McEwen BS, (1999) Hippocampal remodeling and damage by corticosteroids: Implications for mood disorders. Neuropsychopharmacology 21 (4): 474-484.
23. Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, et al. (2007) Persistent cognitive impairment in depression: The role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry 62 (5): 400-406.
24. Egeland J, Lund A, Landro NI, Rund BR, Sundet K, et al. (2005) Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed. Acta Psychiatr Scand 112 (6): 434-441.
25. Zobel AW, Schulze-Rauschenbach S, von Widdern OC, Metten M, Freymann N, et al. (2004) Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment. J Psychiatr Res 38 (4): 377-383.
26. van der Werf-Eldering MJ, Burger H, Holthausen EAE, Aleman A, Nolen WA, (2010) Cognitive functioning in patients with bipolar disorder: Association with depressive symptoms and alcohol use. PloS ONE 5 (9): e13032 doi:10.1371/journal.pone.0013032.
27. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, et al. (1998) The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20): 22-33.
28. Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, et al. (2004) The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychol Med 34 (1): 73-82.
29. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, et al. (2003) The 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54 (5): 573-583.
30. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH, (1996) The inventory of depressive symptomatology (IDS): Psychometric properties. Psychol Med 26 (3): 477-486.
31. Young RC, Biggs JT, Ziegler VE, Meyer DA, (1978) A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133: 429-435.
32. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, et al. (2001) The stanley foundation bipolar treatment outcome network. II. demographics and illness characteristics of the first 261 patients. J Affect Disord 67 (1-3): 45-59.
33. Leverich GS, Nolen WA, Rush AJ, McElroy SL, Keck PE, et al. (2001) The stanley foundation bipolar treatment outcome network. I. longitudinal methodology. J Affect Disord 67 (1-3): 33-44.
34. Nelson HE, (1982) National adult reading test (NART) test manual. Windsor, England NFER Nelson Publishing Company.
35. Lezak MD, Howieson DB, Loring DW, (2004) Neuropsychological assessment. Oxford, New York Oxford University Press.
36. Robbins TW, James M, Owen AM, Sahakian BJ, McInnes L, et al. (1994) Cambridge neuropsychological test automated battery (CANTAB): A factor analytic study of a large sample of normal elderly volunteers. Dementia 5 (5): 266-281.
37. Vreeburg SA, Kruijtzer BP, van Pelt J, van Dyck R, DeRijk RH, et al. (2009) Associations between sociodemographic, sampling and health factors and various salivary cortisol indicators in a large sample without psychopathology. Psychoneuroendocrinology 34 (8): 1109-1120.
38. Kirschbaum C, Hellhammer DH, (1994) Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 19 (4): 313-333.
39. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH, (2003) Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 (7): 916-931.
40. Bhattacharyya MR, Molloy GJ, Steptoe A, (2008) Depression is associated with flatter cortisol rhythms in patients with coronary artery disease. J Psychosom Res 65 (2): 107-113.
41. Preacher KJ, Hayes AF, (2008) Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 40 (3): 879-891.
42. Statistical Package for the Social Sciences (SPSS) 1602forWindows, (2008) SPSS Inc. Chicago.
43. Sapolsky RM, (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (10): 925-935.
44. Starkman MN, Gebarski SS, Berent S, Schteingart DE, (1992) Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with cushing's syndrome. Biol Psychiatry 32 (9): 756-765.
45. Sheline YI, (1996) Hippocampal atrophy in major depression: A result of depression-induced neurotoxicity? Mol Psychiatry 1 (4): 298-299.
46. Schwabe L, Joels M, Roozendaal B, Wolf OT, Oitzl MS, (2011) Stress effects on memory: An update and integration. Neurosci Biobehav Rev.
47. Comijs HC, Gerritsen L, Penninx BW, Bremmer MA, Deeg DJ, et al. (2010) The association between serum cortisol and cognitive decline in older persons. Am J Geriatr Psychiatry 18 (1): 42-50.
48. Keefe RS, (1995) The contribution of neuropsychology to psychiatry. Am J Psychiatry 152(0002-953; 1): 6-15.
49. Aas M, Dazzan P, Mondelli V, Toulopoulou T, Reichenberg A, et al. (2011) Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychol Med 41 (3): 463-476.
50. Rohleder N, Wolf JM, Wolf OT, (2010) Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci Biobehav Rev 35 (1): 104-114.
51. Altena E, Van Der Werf YD, Strijers RL, Van Someren EJ, (2008) Sleep loss affects vigilance: Effects of chronic insomnia and sleep therapy. J Sleep Res 17 (3): 335-343.
52. Grool AM, van der Graaf Y, Mali WP, Geerlings MI, SMART Study Group. (2011) Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: The SMART-medea study. J Neurol Neurosurg Psychiatry 82 (10): 1093-1100.